---
title: "This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290695090.md"
description: "Wall Street analysts downgraded five stocks on Wednesday. Mizuho downgraded Apogee Therapeutics to Neutral with a $135 target. Raymond James downgraded V2X to Market Perform. B of A slashed Principal Financial Group to Underperform, cutting the target to $95. Daiwa Capital downgraded JD.com to Hold. Bernstein downgraded Nuvalent to Market Perform, lowering the target to $124."
datetime: "2026-06-24T12:17:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290695090.md)
  - [en](https://longbridge.com/en/news/290695090.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290695090.md)
generator: "portal-rs"
---

# This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Mizuho analyst Joseph Catanzaro downgraded **Apogee Therapeutics Inc** (NASDAQ:APGE) from Outperform to Neutral and raised the price target from $110 to $135. Apogee Therapeutics shares closed at $132.88 on Tuesday. See how other analysts view this stock.
-   Raymond James analyst Brian Gesuale downgraded **V2X Inc** (NYSE:VVX) from Outperform to Market Perform. V2X shares closed at $83.29 on Tuesday. See how other analysts view this stock.
-   B of A Securities analyst Joshua Shanker downgraded **Principal Financial Group Inc** (NASDAQ:PFG) from Neutral to Underperform and slashed the price target from $98 to $95. Principal Financial shares closed at $132.88 on Tuesday. See how other analysts view this stock.
-   Daiwa Capital analyst John Choi downgraded **JD.Com Inc** (NASDAQ:JD) from Buy to Hold. JD.com shares closed at $26.12 on Tuesday. See how other analysts view this stock.
-   Bernstein analyst Jeffrey Walch downgraded **Nuvalent, Inc** (NASDAQ:NUVL) from Outperform to Market Perform and cut the price target from $172 to $124. Nuvalent shares closed at $123.44 on Tuesday. See how other analysts view this stock.

Considering buying PFG stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [PFG.US](https://longbridge.com/en/quote/PFG.US.md)
- [JD.US](https://longbridge.com/en/quote/JD.US.md)
- [APGE.US](https://longbridge.com/en/quote/APGE.US.md)
- [09618.HK](https://longbridge.com/en/quote/09618.HK.md)
- [NUVL.US](https://longbridge.com/en/quote/NUVL.US.md)
- [VVX.US](https://longbridge.com/en/quote/VVX.US.md)
- [KJD.US](https://longbridge.com/en/quote/KJD.US.md)

## Related News & Research

- [V2X to Participate in the 2026 Jefferies Global Industrials Conference | VVX Stock News](https://longbridge.com/en/news/297543452.md)
- [Principal completes acquisition of Beam Benefits](https://longbridge.com/en/news/297656718.md)
- [BUZZ-Principal Financial Group jumps after report Samsung Life eyeing stake](https://longbridge.com/en/news/297938220.md)
- [United Capital Financial Advisors LLC Invests $970,000 in Principal Financial Group, Inc. $PFG](https://longbridge.com/en/news/297491647.md)
- [02:36 ETEttifos V2X-AIR to Support Major Connected Vehicle Deployment in Arizona](https://longbridge.com/en/news/297607142.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**